000 | 01508 a2200421 4500 | ||
---|---|---|---|
005 | 20250512010452.0 | ||
264 | 0 | _c19900123 | |
008 | 199001s 0 0 eng d | ||
022 | _a0031-6970 | ||
024 | 7 |
_a10.1007/BF00609425 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScott, M G | |
245 | 0 | 0 |
_aHaemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin. _h[electronic resource] |
260 |
_bEuropean journal of clinical pharmacology _c1989 |
||
300 |
_a53-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNorepinephrine _xblood |
650 | 0 | 4 |
_aPrazosin _xpharmacokinetics |
650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aDeering, A H | |
700 | 1 | _aMcMahon, M T | |
700 | 1 | _aHarron, D W | |
700 | 1 | _aShanks, R G | |
773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 37 _gno. 1 _gp. 53-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00609425 _zAvailable from publisher's website |
999 |
_c2597360 _d2597360 |